Orchard Hill Reports a 10% Stake in Supernus Pharmaceuticals

Orchard Hill, Supernus Pharmaceuticals: Earlier this year, Orchard Hill Capital Management purchased a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) which contained...

Keep Reading →